The good news is the Inflation Reduction Act, which puts a $35 cap on monthly insulin prices, went into effect on Jan. 1. The bad
Whenever Congress or state legislatures start talking about capping high drug costs or other legislative solutions, pharmaceutical companies argue that these laws are counterproductive. They argue that they must charge exorbitant prices for new drugs because it pays for the next class of cures.
This past Sunday was National App day. National App day was created by CJ Thompson – founder of the mobile marketing agency Platinum Edge Media
What makes a drug fall into the “specialty” drug category is a combination of several factors. First, they tend to be very expensive. This is because they were recently approved, meaning they are under an active patent with no generic or biosimilar version available.
A new study out by Prescryptive Health, a healthcare technology company, found that while 95% of people know they can comparison shop for drugs, very few do.
Mark Cuban’s eponymous online pharmacy was an interesting new twist in the U.S. drug pricing dilemma this past January. The Cost Plus Drugs Company sells
Recently, RazorMetrics was brought in to be evaluated on our hard numbers: time to ROI, actual savings, and real prescriber response stats. When we pulled
The Inflation Reduction Bill passed the House last November (2021) then it hit the Senate and stalled. After a long pause and some wheeling and dealing, it squeaked by in the Senate on August 7th. Then, it flew back through the House on Friday the 12th and now, will be signed by the President in the coming days. Now that it has passed the legislature, here is what you need to know about how the Inflation Reduction Bill will impact healthcare:
In a recent guest essay in the New York Times entitled, “What’s Wrong With Health Insurance? Deductibles Are Ridiculous, for Starters” by Dr. Aaron E. Carroll, what I found the most interesting was the comment section.
Rigorous, independent audit certifies RazorMetrics has the highest level of data security measures AUSTIN, Texas, July 12, 2022 /PRNewswire/ — RazorMetrics, a SaaS-based drug cost solution platform earned
And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.
